PhaseBio Pharmaceuticals Inc
OTC:PHASQ

Watchlist Manager
PhaseBio Pharmaceuticals Inc Logo
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 49.9 USD

Wall Street
Price Targets

PHASQ Price Targets Summary
PhaseBio Pharmaceuticals Inc

There are no price targets for PHASQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
PhaseBio Pharmaceuticals Inc Competitors:
Price Targets
LXRX
Lexicon Pharmaceuticals Inc
141% Upside
UTHR
United Therapeutics Corp
1% Upside
ENTA
Enanta Pharmaceuticals Inc
20% Upside
BSLN
Basilea Pharmaceutica AG
48% Upside
ARX
Aroa Biosurgery Ltd
24% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
SPRY
ARS Pharmaceuticals Inc
150% Upside
AUPH
Aurinia Pharmaceuticals Inc
5% Upside

Revenue
Forecast

Revenue Estimate
PhaseBio Pharmaceuticals Inc

For the last 1 year the compound annual growth rate for PhaseBio Pharmaceuticals Inc's revenue is 3 285%.

3 285%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
PhaseBio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
PhaseBio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHASQ's stock price target?
Not Available

PHASQ doesn't have any price targets made by Wall Street professionals.

Back to Top